Cytokines as Cellular Communicators

Mediators of Inflammation

Volumn 5, Issue 6, 1996, Pages 417-423

  Debets, R ^a   Savelkoul, H F J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Control of activity; Cytokine; Interference in cytokine activity; Receptor; Signalling routes

Indexed keywords

CHEMOKINE; CYTOKINE; CYTOKINE RECEPTOR;

HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0030460636     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/S0962935196000579     Document Type: Article

References (47)

1. Kornelisse RF, Hazelzet JA, Savelkoul HFJ, Hop WCJ, Suur MH, Borsboom ANJ, Risseeuw-Appel IM, Van Der Voort E, De Groot R. The relationship between plasminogen activator inhibitor-1 and proinflam matory mediators in children with meningococcal septic shock. J Infect Dis. 1996; 173: 1148–1156.
2. Boulay JL, Paul WE. The interleukin-4 family of lymphokines. Curr Opin Immunol. 1993; 3: 573–581.
3. Callard R, Gearing A. The Cytokine Factsbook. London: Academic Press, 1994; 12-27.
4. Debets R, Savelkoul HFJ. Cytokine antagonists and their potential therapeutic use. Immunol Today. 1993; 15: 455–458.
5. Baggiolini M, Dewald B, Moser B. IL-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 1993; 55: 97–179.
6. Boraschi D, Nencioni L, Villa L, Censini S, Bossu P, Ghiara P, Presentini R, Perin F, Frasca D, Doria G, Forini G, Musso T, Giovarelli M, Ghezzi P, Bortini F, Besedovsky HO, Del Rey A, Sipe JO, Antoni G, Silvesta S, Tagliabue A. In vivo stimulation and restoration of the immune response by the non-inflammatory fragment 163-171 of human interleukin 1β. J Exp Med. 1988; 168: 675–686.
7. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA. 1990; 87: 6934–6938.
8. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell. 1994; 76: 253–262.
9. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood. 1995; 86: 1243–1254.
10. Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T. Critical cytoplasmic region of the IL-6 signal transducer, gp130, is conserved in the cytokine receptor family. Proc Natl Acad Sci USA. 1991; 88: 11349–11353.
11. Ihle JN, Witthuhn BA, Quelle F, Yamamoto K, Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol. 1995; 13: 369–398.
12. Amzel LM, Poljak RJ. Three-dimensional structure of immunoglobulins. Annu Rev Biochem. 1979; 48: 961–967.
13. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990; 61: 203–212.
14. Mallett S, Barclay AN. A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol Today. 1991; 12: 220–223.
15. Gerard C, Gerard NP. The pro-inflammatory seven-transmembrane segment receptors of the leucocyte. Curr Opin Immunol. 1994; 6: 140–145.
16. Schindler C, Darnell JE. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem. 1995; 64: 621–651.
17. Ivashkiv LB. Cytokines and STATs: how can signals achieve specificity? Immunity. 1995; 3: 1–4.
18. Ihle JN. Cytokine receptor signalling. Nature. 1995; 377: 591–594.
19. Rose-John S, Heinrich PC. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J. 1994; 300: 281–290.
20. Crowe PD, Walter BN, Mohler KM, Otten-Evans C, Black RA, Ware CF. A metallo-protease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med. 1995; 181: 1205–1210.
21. Miillberg J, Durie FH, Otten-Evans C, Alderson MR, Rose-John S, Cosman D, Black RA, Mohler KM. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol. 1995; 155: 5198–5205.
22. Alcami A, Smith GL. Cytokine receptors encoded by pox viruses: a lesson in cytokine biology. Immunol Today. 1995; 16: 474–478.
23. Hsu D-H, De Waal Malefyt R, Fiorentino DF, Dang MN, Vieira P, De Vries J, Spits H, Mosmann TR, Moore KW. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science. 1990; 250: 830–832.
24. Spriggs MK, Hruby DE, Maliszewski CR, Pickup DJ, Sims JE, Buller RM, Van Slyke J. Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein. Cell. 1992; 71: 153–167.
25. Ahuja SK, Murphy PM. Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. J Biol Chem. 1993; 268: 20691–20694.
26. Chatenoud L. Allograft rejection: the role of the cytokine network. Eur Cyt Network. 1992; 3: 509–513.
27. Ruddle NH. Tumor necrosis factor (TNF-a) and lymphotoxin (TNF-∣3). Curr Opin Immunol. 1992; 4: 327–332.
28. Baily S, Di Giovine FS, Blakemore AI, Duff GW. Genetic polymorphism of human interleukin-1 alpha. Eur J Immunol. 1993; 23: 1240–1245.
29. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 bp tandem repeat. Hum Genet. 1993; 91: 403–404.
30. Cosman D. Control of messenger RNA stability. Immunol Today. 1987; 8: 16–17.
31. Schindler R, Clark BD, Dinarello CA. Dissociation between interleukin-1β mRNA and protein synthesis in human peripheral blood mono nuclear cells. J Biol Chem. 1990; 265: 10232–10237.
32. Massague J, Pandiella A. Membrane-anchored growth factors. Annu Rev Biochem. 1993; 62: 515–541.
33. Howard AD, Kostura MJ, Thornberry N, Ding G-JF, Limjuco G, Weidner J, Salley JP, Hogquist KA, Chaplin DD, Mumford RA, Schmidt JA, Tocci MJ. IL-1-converting enzyme requires aspartic acid residues for proces sing of the IL-1β precursor at two distinct sites and does not cleave 31- kDa IL-la. J Immunol. 1991; 147: 2964–2969.
34. Schroder JM. Cytokine networks in the skin. J Invest Dermatol. 1995; 105: 20S–24S.
35. Hazuda DJ, Strickler J, Kueppers F, Simon PL, Young PR. Processing of precursor interleukin 1 beta and inflammatory disease. J Biol Chem. 1990; 265: 6318–6322.
36. Harpel JG, Metz CN, Kojima S, Rifkin DB. Control of transforming growth factor-beta activity: latency vs. activation. Prog Growth Factor Res. 1993; 4: 321–335.
37. Seghal PB. Interleukin 6: molecular pathophysiology. J Invest Dermatol. 1990; 94: 2S–6S.
38. Van Damme J, Van Beeumen J, Conings R, Decock B, Billiau A. Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of beta-thromboglobulin. Eur J Biochem. 1989; 81: 337–344.
39. Opdenakker G, Rudd PM, Wormald M, Dwek RA, Van Damme J. Cells regulate the activities of cytokines by glycosylation. FASEB J. 1995; 9: 453–457.
40. Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leucocytes. Immunol Today. 1993; 14: 111–115.
41. Cosman D. The hematopoietin receptor superfamily. Cytokine. 1993; 5: 95–106.
42. Bendtzen K, Svenson M, Jonsson V, Hippe F. Autoantibodies to cytokines—friends or foes? Immunol Today. 1990; 11: 167–169.
43. Sylvester I, Suffredini AF, Boujoukos AJ, Martich GD, Danner RL, Yoshimura T, Leonard EJ. Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum. Effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes. J Immunol. 1993; 151: 3292–3298.
44. Klein B, Brailly H. Cytokine-binding proteins: stimulating antagonists. Immunol Today. 1995; 16: 216–220.
45. Eisenberg SP, Evan RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990; 343: 341–346.
46. Atamas SP, Choi J, Yurovsky W, White B. An alternative splice variant of human IL-4, IL-462, inhibits IL-4-stimulated T cell proliferation. J Immunol. 1996; 156: 435–441.
47. Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YC, Hakimi J. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol. 1995; 154: 116–127.